Advertisement

---

ACELRX PHARMACEUTICALS, INC.

AcelRx Pharmaceuticals Joins Russell Global and Russell 3000 Indexes

[2013-07-02] -


AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events

[2013-07-01] -


AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013

[2013-06-21] -


AcelRx Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare

[2013-05-29] -


Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain

[2013-05-21] - - Following major orthopedic surgery, Sufentanil NanoTab-treated patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p<0.001) -
- Results confirm all previously reported Phase 3 trial outcomes, supporting submission of an NDA anticipated for third quarter 2013 -
- AcelRx to conduct conference call and webcast today, May 21, 8:30 a.m. EDT (5:30 a.m. PDT) -


AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results

[2013-05-08] -


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers